Research News

Statins Present New Directions for Ovarian Cancer Research

(3/17/2020) Research out of the University of Bristol looked at genes and how they inhibit an enzyme involved in regulating the body’s cholesterol. This enzyme is the target of statin drugs, which are prescribed to lower cholesterol levels…

Read on

PARP Inhibitors in Ovarian Cancer Treatment: What’s Next?

(February 13, 2020) PARP inhibitors have shown to be a promising treatment option for a subset of ovarian cancer patients…

Read on

Conversation on Link Between Talcum Powder and Ovarian Cancer Continues with New Prospective Study

(January 15, 2020) A new study in the Journal of the American Medical Association (JAMA) found no statistically significant association between self-reported use of powder in the genital area and subsequent risk of developing ovarian cancer…

Read on

OCRA Awards $6.6 Million in Ovarian Cancer Research Grants for 2020

(January 13, 2020) Thanks to your support, 22 top scientists at 19 eminent medical centers across the world will delve into important topics across the ovarian cancer landscape…

Read on

OCRA-Funded Research Advances Immunotherapy

(December 23, 2019) OCRA-funded scientist Dr. Sarah Gitto is making strides toward better harnessing the immune system to fight ovarian cancer. As reported recently in Gynecologic Oncology, Dr…

Read on

OCRA-Funded Research Breakthroughs in 2019

OCRA-funded scientists have been hard at work this year, uncovering breakthroughs in ovarian cancer prevention, diagnostics, and treatment that can save women’s lives…

Read on

OCRA Research Reveals Two Cells of Origin for High Grade Ovarian Cancer

(December 3, 2019) The origins of high grade serous ovarian carcinoma (HGSOC) is a debated topic in the scientific community…

Read on

OCRA-Funded Research Yields Insight into Clear Cell Ovarian Cancers

(November 13, 2019) A study recently published in Nature Communications and led by OCRA grantee Dr. Rugang Zhang showed that the ARID1A protein plays a fundamental role in ensuring correct chromosome segregation when the cells divide…

Read on

IUD May Lower Risk of Developing Ovarian Cancer

(November 6, 2019) A recent research review conducted by a team at the University of Colorado Anschutz, and published this month by the American College of Obstetrics and Gynecology, found that use of an intrauterine device (IUD) was associated with…

Read on

OCRA-Funded Research Explores New Pathways for Understanding Metastases

(October 30) In an effort to further understand disease initiation and progression, OCRA grantee Dr…

Read on

PARP Inhibitor and Chemotherapy Combination Improves Progression-Free Survival

(October 7, 2019) Published recently in the New England Journal of Medicine, a group of investigators led by OCRA Scientific Advisory Committee member Dr…

Read on

OCRA-Funded Research Elucidates New Immunotherapy Approach

(September 19, 2019) While harnessing the immune system has resulted in strong responses for a subset of cancer patients, the majority of patients have remained unresponsive to this approach…

Read on